GB1079265A - A powder containing as active material furazolidone - Google Patents

A powder containing as active material furazolidone

Info

Publication number
GB1079265A
GB1079265A GB3035765A GB3035765A GB1079265A GB 1079265 A GB1079265 A GB 1079265A GB 3035765 A GB3035765 A GB 3035765A GB 3035765 A GB3035765 A GB 3035765A GB 1079265 A GB1079265 A GB 1079265A
Authority
GB
United Kingdom
Prior art keywords
sodium
furazolidone
mono
oil
agar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3035765A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abic Ltd
Original Assignee
Abic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL23799A external-priority patent/IL23799A/en
Application filed by Abic Ltd filed Critical Abic Ltd
Publication of GB1079265A publication Critical patent/GB1079265A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Furazolidone powders capable of forming stable aqueous suspensions comprise furazolidone, a wetting agent and one or more of (a) a monosaccharide (b) a disaccharide (c) a water-soluble or water-swellable gum (d) a sugar derivative (e) a dispersing agent and (f) an oily substance. The wetting agent may be anionic, e.g. tetrasodium N-(1,2 dicarboxyethyl) N-octadecylsulpho succinate sodium lauryl sulphate, or sodium dioctyl sulpho-succinate; cationic e.g. diisobutyl phenoxyethoxyethyl dimethyl benzyl ammonium chloride, or cetrimide; or non-ionic, e.g. polyoxyethylene sorbitan mono-laurate, palmitate, stearate, or oleate, a fatty alcohol polyglycol ether, or octylphenoxypolyethoxy ethanol. The mono- and di-saccharides may be glucose and sucrose respectively. Specified gums include gum arabic, acacia, agar-agar, pectin, tragacanth, gelatin, carboxymethylcellulose, methylcellulose, dextran and alginates, e.g. sodium alginate. The sugar derivative may be an alcohol or an ester of a mono-, di-, tri- or tetra-saccharide e.g. mannitol or sorbitol. The dispersing agent may be a polymerised salt of an alkyl-aryl sulphonic acid, sodium lignin sulphonate, or polyethylene glycol 4000 or 6000. The oily substance may be a mineral oil, e.g. paraffin oil or an animal or vegetable oil or fat, e.g. olive oil. Fillers such as NaCl, Na2SO4, MgSO4, SiO2 may be incorporated in the powder. Alkaline substances such as alkali metal salts of weak acids e.g. sodium benzoate, sodium salicylate, sodium acetate, sodium citrate, sodium and potassium bicarbonate and sodium and potassium hydrogen phosphate may also be added to the powder so that the aqueous suspension will have a physiological pH.
GB3035765A 1964-07-22 1965-07-16 A powder containing as active material furazolidone Expired GB1079265A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL2174064 1964-07-22
IL23799A IL23799A (en) 1964-07-07 1965-06-24 Powder containing as active material furazolidone

Publications (1)

Publication Number Publication Date
GB1079265A true GB1079265A (en) 1967-08-16

Family

ID=26320412

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3035765A Expired GB1079265A (en) 1964-07-22 1965-07-16 A powder containing as active material furazolidone

Country Status (3)

Country Link
DE (1) DE1617273A1 (en)
GB (1) GB1079265A (en)
NL (1) NL6509059A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006752A1 (en) * 1988-12-22 1990-06-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Veterinary composition and a process for the preparation thereof
EP0782850A1 (en) * 1994-10-13 1997-07-09 Wakamoto Pharmaceutical Co., Ltd. Lyophilized preparation providing reversibly thermogelling water-base medicinal composition
US5914320A (en) * 1996-07-19 1999-06-22 The Procter & Gamble Company Co-milled mixtures comprising polyol and method of making

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473307A1 (en) * 1979-12-10 1981-07-17 Grimberg Georges Aq. suspensions of di:hydroxy di:butyl ether - contg. mucilaginous or gelling agent are choleretics and spasmolytics

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006752A1 (en) * 1988-12-22 1990-06-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Veterinary composition and a process for the preparation thereof
EP0782850A1 (en) * 1994-10-13 1997-07-09 Wakamoto Pharmaceutical Co., Ltd. Lyophilized preparation providing reversibly thermogelling water-base medicinal composition
EP0782850A4 (en) * 1994-10-13 1998-03-04 Wakamoto Pharma Co Ltd Lyophilized preparation providing reversibly thermogelling water-base medicinal composition
US5914320A (en) * 1996-07-19 1999-06-22 The Procter & Gamble Company Co-milled mixtures comprising polyol and method of making

Also Published As

Publication number Publication date
DE1617273A1 (en) 1971-02-18
NL6509059A (en) 1966-01-24

Similar Documents

Publication Publication Date Title
KR900013845A (en) Agrochemical or bactericidal suspensions
GB1465347A (en) Composition
ES353647A1 (en) Shampoo composition
KR900700093A (en) Water Soluble Ibuprofen Formulation and Manufacturing Method Thereof
GB1524740A (en) Pharmaceutical compositions for use in the suppression of gastric reflux
ES2064112T3 (en) PHARMACEUTICAL COMPOSITION FOR QUICK SUSPENSION IN WATER.
PL335386A1 (en) Body cleaning agent
SE8504441L (en) HIGH-FOAM, PA NONJONIC SURFACTANT AGENT DETERGENT
ES2053838T3 (en) A BUBBLE BATH PREPARATION THAT DOES NOT FOAM.
GB1079265A (en) A powder containing as active material furazolidone
GB1026493A (en) Dry,vitamin-active product and process for preparing same
GB1417003A (en) Stabilisation of fibrinogen
GB1458430A (en) Abradant skin cleanser
IE36536B1 (en) Improved herbicidal compositions
ES2059120T5 (en) AQUEOUS LIQUID CLEANING AGENT.
GB1353635A (en) Coating composition for moist surfaces
GB1235801A (en) A process for the manufacture of rapidly-disintegrating solid dosage unit forms
ES2032470T3 (en) AN EMULSION OF OIL IN WATER.
GB1275407A (en) A method of producing an edible foam-product
GB1499240A (en) Ascorbic acid preparations
GB739936A (en) Chlorophyll preparations
GB1355985A (en) Solid slow release preparation of prolonged action
GB1389890A (en) Method for preparing particulate pharmaceutical preparations
ES2029337T3 (en) I DENTRIFY WITH BRUSHING TIME INDICATOR.
GB1189481A (en) Stable Liquid Compositions of Matter